A Noninvasive Urine Test Can Detect Cancer Cells
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read MorePosted by Chris Wolski | Jul 16, 2021 | Colorectal, Urinalysis & Toxicology |
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read MorePosted by Chris Wolski | Jul 9, 2021 | Cancer |
Cancer screening tests rebounded in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic.
Read MorePosted by Chris Wolski | Jul 2, 2021 | Diagnostic Technologies |
University of Michigan researchers have found evidence suggesting that preoperative testing is often unnecessary for low-risk surgeries.
Read MorePosted by Melanie Hamilton-Basich | Jun 22, 2021 | Digital Pathology |
Epredia has been appointed as a global distribution partner for Aiforia’s portfolio of preclinical and clinical pathology tools, including segment exclusivity for distribution in the United States.
Read MorePosted by Melanie Hamilton-Basich | May 24, 2021 | Lung Cancer |
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read More